APOA5 and coronary artery disorder: Subsequent studies revealed that loss-of-function mutations in human APOA5 are associated with high plasma TG levels (2, 3, 4, 5, 6, 7) and an increased risk of atherosclerotic coronary artery disease (2, 8, 9).